BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 10922477)

  • 1. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
    FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
    Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
    J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
    Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
    Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
    Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
    J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
    Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D
    J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy.
    Podewski EK; Hilfiker-Kleiner D; Hilfiker A; Morawietz H; Lichtenberg A; Wollert KC; Drexler H
    Circulation; 2003 Feb; 107(6):798-802. PubMed ID: 12591746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tyrosine 974 within the LIF-R-chain of the gp130/LIF-R heteromeric receptor complex mediates negative regulation of LIF signalling.
    Clahsen T; Lehmann U; Stross C; Hermanns HM; Volkmer-Engert R; Schneider-Mergener J; Heinrich PC; Schaper F
    Cell Signal; 2005 May; 17(5):559-69. PubMed ID: 15683731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
    Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
    J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
    Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
    Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
    Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
    Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130.
    Lehmann U; Schmitz J; Weissenbach M; Sobota RM; Hortner M; Friederichs K; Behrmann I; Tsiaris W; Sasaki A; Schneider-Mergener J; Yoshimura A; Neel BG; Heinrich PC; Schaper F
    J Biol Chem; 2003 Jan; 278(1):661-71. PubMed ID: 12403768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors.
    Stahl N; Farruggella TJ; Boulton TG; Zhong Z; Darnell JE; Yancopoulos GD
    Science; 1995 Mar; 267(5202):1349-53. PubMed ID: 7871433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
    Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
    Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.
    Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G
    FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3.
    Niemand C; Nimmesgern A; Haan S; Fischer P; Schaper F; Rossaint R; Heinrich PC; Müller-Newen G
    J Immunol; 2003 Mar; 170(6):3263-72. PubMed ID: 12626585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling of type II oncostatin M receptor.
    Auguste P; Guillet C; Fourcin M; Olivier C; Veziers J; Pouplard-Barthelaix A; Gascan H
    J Biol Chem; 1997 Jun; 272(25):15760-4. PubMed ID: 9188471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involving of the cytoplasmic region of leukemia inhibitory factor receptor alpha subunit, IL-6 related signal transducer-gp130 or fas death domain for MAPK p42/44 activation in HL-60 cell with LIF or anti-Fas IgG.
    Liu H; Dan J; Tang S; Wu S
    Mol Cell Biochem; 2001 Jan; 217(1-2):113-20. PubMed ID: 11269654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent roles of SOCS-3 and SHP-2 in the regulation of neuronal gene expression by leukemia inhibitory factor.
    Bartoe JL; Nathanson NM
    Brain Res Mol Brain Res; 2002 Nov; 107(2):108-19. PubMed ID: 12425940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.